Phillips Medisize

Two scientists walking in a manufacturing plant in sterile coveralls and face masks demonstrating CDMO quality and regulatory services using laptop computer.

From Dis­cov­ery to De­liv­ery, We Build Trust

As a contract development and manufacturing organization (CDMO), the world’s leading pharmaceutical, medtech and in vitro diagnostic companies trust us to help them design and manufacture their products. Across the US, Europe and Asia, we engage with each customer we are privileged to serve in a tailored, highly personalized way by listening, asking questions and embracing your engineering challenges. That’s because we believe the C in CDMO also represents Care – the Care we take in engineering your products and the Care these devices ultimately deliver to patients.

A female scientist working in a formulation and development lab at Vectura working on inhalation capabilities
Adding market-leading inhalation capabilities to our suite of drug delivery device design and production capabilities
Combining the strengths of Phillips Medisize and Vectura enhances our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical partners and to fulfill our shared vision of helping patients live healthier lives. Learn More.
Phillips Medisize employee working in the pharmaceutical technology service lab, while we can see another employee walk past outside the window. Through the window, another corridor shows another employee in a neighbouring room.
Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited
Vectura is a leader in inhalation drug device design and formulation, based in Chippenham, United Kingdom. Read more.
Respiratory Drug Delivery Scientist
Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery (RDD) Conference
Experts highlight innovations and developments in inhalation product development. Read more.